BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang X, Bao C, Lv Q, Zhao J, Wang Y, Lang X, Li Z, Yi Z. Sex difference in cognitive impairment in drug-free schizophrenia: Association with miR-195 levels. Psychoneuroendocrinology 2020;119:104748. [PMID: 32559610 DOI: 10.1016/j.psyneuen.2020.104748] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Jin M, Zhu X, Sun Y, Li Z, Li X, Ai L, He Y, Liu Y, Jia N, Hu G, Cui X, Xie M, Yang Y, Yu Q. Identification of Peripheral Blood miRNA Biomarkers in First-Episode Drug-Free Schizophrenia Patients Using Bioinformatics Strategy. Mol Neurobiol. [DOI: 10.1007/s12035-022-02878-4] [Reference Citation Analysis]
2 Li W, Lin S, Yue L, Fang Y, Xiao S. Sex Differences in Obesity and Cognitive Function in Chinese Elderly Patients With Chronic Schizophrenia. Front Endocrinol 2022;13:742474. [DOI: 10.3389/fendo.2022.742474] [Reference Citation Analysis]
3 Santos S, Ferreira H, Martins J, Gonçalves J, Castelo-branco M. Male sex bias in early and late onset neurodevelopmental disorders: shared aspects and differences in autism spectrum disorder, attention deficit/hyperactivity disorder, and schizophrenia. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
4 Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. J Neuroinflammation 2021;18:202. [PMID: 34526062 DOI: 10.1186/s12974-021-02261-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li Z, Liu X, Xu H, Zhao L, Zhou Y, Wu X, Huang X, Lang X, Wu F, Zhang X. Sex Difference in Comorbid Depression in First-Episode and Drug-Naive Patients With Schizophrenia: Baseline Results From the Depression in Schizophrenia in China Study. Psychosom Med 2021;83:1082-8. [PMID: 34419998 DOI: 10.1097/PSY.0000000000000998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shen H, Zhang L, Li Y, Zheng D, Du L, Xu F, Xu C, Liu Y, Shen J, Li Z, Cui D. Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study. Psychol Med . [DOI: 10.1017/s0033291721002944] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang Q, He H, Bai X, Jiang L, Chen W, Zeng X, Li Y, Teixeira AL, Dai J. Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese. Front Psychiatry 2021;12:702720. [PMID: 34305687 DOI: 10.3389/fpsyt.2021.702720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Florian IA, Buruiana A, Timis TL, Susman S, Florian IS, Balasa A, Berindan-Neagoe I. An Insight into the microRNAs Associated with Arteriovenous and Cavernous Malformations of the Brain. Cells 2021;10:1373. [PMID: 34199498 DOI: 10.3390/cells10061373] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Huang Y, Wu K, Jiang R, Zeng X, Zhou S, Guo W, Feng Y, Zou C, Li H, Li T, Ning Y, Yang M, Wu F. Suicide Attempts, Neurocognitive Dysfunctions and Clinical Correlates in Middle-Aged and Elderly Chinese Schizophrenia Patients. Front Psychiatry 2021;12:684653. [PMID: 34122196 DOI: 10.3389/fpsyt.2021.684653] [Reference Citation Analysis]
10 Brébion G, Núñez C, Lombardini F, Senior C, Sánchez Laforga AM, Siddi S, Usall J, Stephan-Otto C. Subclinical depression and anxiety impact verbal memory functioning differently in men and women -an fMRI study. J Psychiatr Res 2021;140:308-15. [PMID: 34126425 DOI: 10.1016/j.jpsychires.2021.05.063] [Reference Citation Analysis]
11 Kobori A, Miyashita M, Miyano Y, Suzuki K, Toriumi K, Niizato K, Oshima K, Imai A, Nagase Y, Yoshikawa A, Horiuchi Y, Yamasaki S, Nishida A, Usami S, Takizawa S, Itokawa M, Arai H, Arai M. Advanced glycation end products and cognitive impairment in schizophrenia. PLoS One 2021;16:e0251283. [PMID: 34038433 DOI: 10.1371/journal.pone.0251283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Pan S, Feng W, Li Y, Huang J, Chen S, Cui Y, Tian B, Tan S, Wang Z, Yao S, Chiappelli J, Kochunov P, Chen S, Yang F, Li CR, Tian L, Tan Y, Elliot Hong L. The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure. Transl Psychiatry 2021;11:117. [PMID: 33558459 DOI: 10.1038/s41398-021-01240-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhou Y, Song X, Guo Y, Lang X, Li Z, Zhang XY. Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. Psychoneuroendocrinology 2021;124:105061. [PMID: 33291004 DOI: 10.1016/j.psyneuen.2020.105061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]